1. Introduction {#s0005}
===============

Loss-of-function mutations in *SCN5A*, that encodes the alpha-subunit of the cardiac Na channel, lead to variable phenotypes, viz. Brugada syndrome (BrS), progressive cardiac conduction disease, atrial fibrillation, and sick sinus syndrome (SSS) [@bib1]. In young children carrying *SCN5A* mutations, reportedly, cardiac conduction disturbance appears as the most common manifestation of disease, with both atrial and ventricular arrhythmia [@bib2]. The phenotype of the patients with the same *SCN5A* mutations is variable because various modifiers might modulate it. We describe a proband, and his family members with a novel nonsense *SCN5A* mutation, who displayed variable phenotypes, and searched for the genetic modifiers that might affect the phenotype.

2. Material and methods {#s0010}
=======================

Gene analysis was performed for the proband, his parents, and two siblings as summarized in the family tree ([Fig. 1](#f0005){ref-type="fig"}) on obtaining the consents of the family members. Genomic DNA was isolated from blood lymphocytes, and screened for the open reading frame of *KCNQ1*, *KCNH2*, *KCNE1-3*, *KCNE5*, *KCNJ2*, and *SCN5A*. Genetic screening was performed using denaturing high-performance liquid chromatography (dHPLC WAVE system, Transgenomic, Omaha, NE, USA). For abnormal screening patterns, direct sequencing was performed using an automated sequencer (ABI PRISM, 3100x, Applied Biosystems, Foster City, CA, USA). For detection of the genetic modifiers, we performed targeted panel sequencing for coding region of 46 genes ([Supplementary information](#s0055){ref-type="sec"}) that were related to primary arrhythmia syndrome for proband and 4 family members, using a bench-top next generation sequencer, the MiSeq (Illumina, San Diego, CA, USA). We then evaluated the detected variants by frequently referring to the NCBI dbSNP database (<http://www.ncbi.nlm.nih.gov/snp/>), Human Genetic Variation Browser that is a Japanese SNP database <http://www.genome.med.kyoto-u.ac.jp/SnpDB/>), and the 1000 genomes database (<http://www.1000genomes.org/home>). The pathogenicity of the variants was estimated by three different types of prediction software: (1) combined annotation dependent depletion (CADD) ([http://cadd.gs.washington.edu/](http://www.cadd.gs.washington.edu/){#ir0020}), (2) PolyPhen-2 ([http://genetics.bwh.harvard.edu/pph2/](http://www.genetics.bwh.harvard.edu/pph2/){#ir0025}), and (3) SIFT ([http://sift.jcvi.org/](http://www.sift.jcvi.org/){#ir0030}).

3. Results {#s0015}
==========

3.1. Case presentation {#s0020}
----------------------

Index proband was a 13-year-old (yo) boy who was suspected to have a sino-atrial block because of an auscultation abnormality at the age of three (family tree in [Fig. 1](#f0005){ref-type="fig"}). At age four, he presented with pre-syncope and underwent electrophysiological test. His PR interval was 179 ms, QRS was 107 ms, and QT interval was 394 ms (QTcF 451 ms). The sinus node recovery time was significantly prolonged to 7,268 ms, and HV interval to 70 ms. The atrio-ventricular nodal effective refractory period was 360 ms. Against a diagnosis of SSS a dual chamber pacemaker was implanted. At the age of 13, he had cardio-pulmonary arrest on running. The electrocardiogram (ECG) monitored by an autonomic external defibrillator (AED) showed ventricular fibrillation (VF) ([Fig. 2](#f0010){ref-type="fig"}A), which was successfully restored to sinus rhythm. On complete recovery, his resting ECG in V2 showed ST elevation of a saddleback type at the 4th, and coved type at the 3^rd^ intercostal leads sites ([Fig. 2](#f0010){ref-type="fig"}B). During atrial pacing at 60 bpm, his PR interval prolonged to 262 ms, QRS interval was 125 ms, and QTc was 436 ms ([Table 1](#t0005){ref-type="table"}). [Fig. 2](#f0010){ref-type="fig"}C depicts temporal changes in the ECG (V1-V3) recorded from the age 4 to 13. At age 4, we failed to find any Brugada pattern, while the J point gradually elevated from the age of 9. An echocardiographic examination revealed no structural abnormalities. The signal averaged electrocardiogram (SAECG) revealed positive late potentials, and microvolt-T wave alternans (μV-TWA) was negative. He, therefore, was diagnosed with BrS. His pacemaker was replaced with an implantable cardioverter defibrillator (ICD).

3.2. Phenotypes of the family members {#s0025}
-------------------------------------

The proband had asymptomatic parents and two siblings as shown in the family tree in [Fig. 1](#f0005){ref-type="fig"}. All except for his father had abnormal ECG. His mother (46-yo) had a coved type ST elevation in the 3rd precordial leads ([Fig. 3](#f0015){ref-type="fig"}A). His elder sister (19-yo) had SSS, and a coved type Brugada ECG during a pilsicainide (class Ic antiarrhythmia drug) challenge test ([Fig. 3](#f0015){ref-type="fig"}B), and his elder brother (21-yo) had a saddle back Brugada ECG during pilsicainide administration ([Fig. 3](#f0015){ref-type="fig"}C). We injected 1 mg/kg of pilsicainide for 10 minutes. The prolongation of the PR interval was detected in his mother at rest, and in his sister and brother on pilsicainide administration ([Table 1](#t0005){ref-type="table"}). They were all positive for SAECG and negative for μV-TWA. His maternal grandfather, who died of cancer, had received a pacemaker for SSS. We obtained his ECG recording that showed sinus rhythm at 70 bpm, a PR interval of 190 ms, QRS duration of 106 ms, and no Brugada ECG pattern (data not shown).

3.3. Genetic analyses {#s0030}
---------------------

We identified a *SCN5A* mutation in the proband, and the three family members except for his father. The mutation, a single-base substitution at nucleotide 2335 (c.2335C\>T), is located in the cytoplasmic loop of the Na channel alpha-subunit and changed the codon CAG (glutamine: Q) to an in-frame stop codon, TAG, at position 779, Q779X ([Fig. 4](#f0020){ref-type="fig"}). A premature stop codon in this position results in nonsense mediated decay (NMD), leading to decay of mRNA [@bib3]. Therefore, the expression level of mRNA and protein of cardiac Na channel is presumably low in SCN5A-Q779X carriers.

To clarify the phenotypic variation among the mutant *SCN5A* carriers in the index family, we performed a targeted panel sequence using MiSeq, for the mutation carriers. In the analysis, we further detected four non-synonymous variants of arrhythmia-related genes in the proband, his mother and his sister, but not in his brother exhibiting a milder phenotype. The first one was desmoglein 2 (*DSG2*)-R773K (rs2278792) and the others were *SCN1B* L210P (rs55742440,), S248R (rs67701503), and R250T (rs67486287). *DSG2* is one of the desmosomal genes whose mutations cause arrhythmogenic right ventricular cardiomyopathy. *SCN1B* encodes an ancillary beta-subunit of the cardiac Na^+^ channels and affects the cardiac conduction, and was reported as a causative gene for BrS. [Table 2](#t0010){ref-type="table"} summarizes Minor allele frequencies (MAF) and prediction scores for the pathogenicity of each variant. None of them seemed to be the main cause of the disease because their MAFs of them were greater than 0.1, and were predicted to be of benign or mild pathogenicity.

4. Discussion {#s0035}
=============

We identified a novel, heterozygous nonsense *SCN5A* mutation, Q779X, in a family with overlapped phenotype with progressive conduction defects and BrS. The proband suffered from SSS at the age of three, and subsequent ventricular fibrillation with a coved type Brugada ECG pattern at age of 13 was detected. Mild prolongation of the HV intervals had been observed at the age of four, indicating the presence of an extensive conduction delay. At 9 years of age, a right precordial ECG abnormality became gradually significant.

SSS is complicated in children with a left isomerism heart [@bib4], or on surgical intervention for congenital heart disease [@bib5]. It is also seen in channelopathies such as long QT syndrome, BrS [@bib6], or as a part of a progressive cardiac conduction disease [@bib7]. *SCN5A* mutations are known to be associated with all these phenotypes. Loss-of-function *SCN5A* mutants have been shown to be related to BrS as well as profound bradyarrhythmias [@bib8]. In children with these mutations, prolonged cardiac conduction intervals have been reported to emerge as the most common manifestation of the disease, and are accompanied with both atrial and ventricular arrhythmias [@bib2]. Three genotype-positive children in our family shared similar clinical characteristics.

The intravenous challenge test with a Na^+^ channel blocker was conducted in two of our genotype-positive members, and the drug produced PR prolongation ([Table 1](#t0005){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"}). The PR prolongation, which results from common loss-of-function *SCN5A* mutation, was enhanced by a Na^+^ channel blocker in our family members.

The heterozygous nonsense *SCN5A* mutation of the family was at amino acid 779 that lies in the middle of the cytoplasmic loop of domain 2 ([Fig. 4](#f0020){ref-type="fig"}, topography). A missense *SCN5A* mutation at the same position, Q779K, was previously reported for a Japanese pedigree of long QT syndrome, which harbored a compound heterozygous mutation, E284K, in *KCNQ1* [@bib9]. A change in the residual charge from neutral (Q: glutamine) to basic (K: lysine) may cause a gain-of-function outcome. In contrast, the nonsense mutation at the same codon leads to NMD [@bib3], thereby exerting severe loss-of-function effects.

The index boy presented progressive conduction defects and VF during earlier stage of his life. His mother and two siblings had similar ECG abnormalities at rest and when challenged with Na-channel blockers, but remained asymptomatic in spite of the same nonsense *SCN5A* mutation. This variation in phenotypic severity could be partially explained by the gender difference, because BrS is predominantly noted in males as the disease has an autosomal-dominant mode of transmission [@bib10].

The reason for the variation in phenotypic severity between the index boy and his elder brother is unknown. Both had the same *SCN5A* mutation, however, the proband had additional *DSG2* and *SCN1B* variants. These variants could be modifiers for the phenotype. *DSG2* is located on chromosome 18, and encodes a calcium-binding transmembrane glycoprotein component of desmosomes, desmoglein 2. Few mutations in *DSG2* have been shown to decrease the Na^+^ current, leading to conduction disturbances, and are associated with arrhythmogenic right ventricular dysplasia [@bib11]. The *SCN1B* gene encodes a beta-1 subunit of the sodium channel that is known to modulate the sodium channel through a non-covalent interaction with the alpha-subunit encoded by *SCN5A*. MAF for each variant was not low, indicating that they were not pathogenic mutations; although, the pathogenicity estimation scores of *SCN1B*-S248R and R250T were relatively high ([Table 2](#t0010){ref-type="table"}). Therefore, the phenotype variation among the *SCN5A*-Q779X carriers could be partially explained by modifier effects of these variants, in addition to the gender difference.

We could only once record the ECGs of family members; therefore, we might have failed to record coved type Brugada pattern ECG, which might have been recorded during follow-up. We did not perform functional analysis of genetic modifiers to confirm the effect on the phenotype. Additionally, we only screened 46 genes related with cardiac arrhythmias, and did not screen introns that might affect the transcription or expression. Thus, we might have overlooked mutation in other genes or in the intronic regions that could be related to the phenotype.

5. Conclusion {#s0040}
=============

*SCN5A*-positive proband and the female members of the family with overlap syndrome phenotype carried additional variants in *SCN1B* and *DSG2*. In contrast, these variants were absent in their *SCN5A*-positive male family member who showed a milder phenotype. Therefore, in addition to the gender difference, *SCN1B* and *DSG2* variants could be modifiers of BrS and SSS phenotypic expression, and our results may help explain the enigma of variable phenotypes for those with *SCN5A* mutations.
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![Pedigree of the family. Phenotypic traits are designated within pedigree symbols. NA: not available for clinical and genetic information.](gr1){#f0005}

![Clinical characteristics of proband. A: Ventricular fibrillation recorded by an automated external defibrillator in the thirteen year old B: Twelve leads ECG, arrows present Brugada ECG C: Temporal changes of ECG in 4th intercostal leads.](gr2){#f0010}

![Family׳s ECG in right precordial leads. A: Mother׳s ECG, left: 4th intercostal leads, right: 3rd intercostal leads Coved type ECG was exhibited in 3rd intercostal leads. B: Elder sister׳s ECG, left: rest ECG, right: 3rd ICL lead on pilsicainide administration SSS and coved type ECG was exhibited during pilsicainide administration C: Elder brother׳s ECG, left: rest ECG, middle: 3rd ICL leads, right: 3rd ICL lead on pilsicainide administration Saddle back like ECG was exhibited during pilsicainide administration.](gr3){#f0015}

![Genetic analysis of the proband. A: Electropherograms of SCN5A gene showing a mutation, p.Q779X (c.2335C\>T) in the proband. B: Topology of sodium channel, voltage-gated, type V, alpha subunit encoded by *SCN5A*. Q779 is located in the cytoplasmic loop connecting segments 3 and 4 of domain 2.](gr4){#f0020}

###### 

Summary of electrophysiological property of the pedigree.

Table 1

            **Age**   **symptom**   **Rest ECG**   **3**rd **ICLs**   **Pilsicainide administration**   **HR**                 **PR interval**   **QRS interval**   **QTc Bazett's**
  --------- --------- ------------- -------------- ------------------ --------------------------------- ---------------------- ----------------- ------------------ ------------------
  Proband   13 y.o.   SSS, VF       Saddle back    Coved              n.d.                              60 bpm atrial pacing   262 ms            125 ms             436 ms
  Mother    46 y.o.   None          Normal         Coved              n.d.                              68 bpm                 215 ms            128 ms             445 ms
  Sister    19 y.o.   None          Normal         Normal             Coved                             57 bpm (44 bpm)        188 ms (214 ms)   112 ms (148 ms)    424 ms (418 ms)
  Brother   21 y.o.   None          Normal         Normal             Saddle back                       68 bpm (75 bpm)        185 (216 ms)      134 ms (134 ms)    427 ms (401 ms)

The values in the pilsicainide administration are given in parentheses.

ICL: intercostal lead, y.o.: years old, SSS: sick sinus syndrome, VF ventricular fibrillation, n.d.: not done.

###### 

MAF and prediction scores of each variation.

Table 2

  Gene    Variation   rsID         NCBI MAF   JP MAF   CADD   PolyPhen2   SIFT
  ------- ----------- ------------ ---------- -------- ------ ----------- ------
  DSG2    R773K       rs2278792    0.24       0.488    11.3   0.014       0.29
  SCN1B   L210P       rs55742440   0.3776     0.273    8.3    0           0.09
          S248R       rs67701503   0.1274     0.178    14.1   0.504       0
          R250T       rs67486287   0.1192     0.178    11.8   0.402       0

CADD: combined annotation dependent depletion, MAF: minor allele frequency.
